Solange Landreville
Chercheuse universitaire
Axe Médecine régénératrice
Ophtalmologie
Métastases et progression du cancer
Tumeurs cancéreuses solides
Thérapie génique et moléculaire
Biologie cellulaire et moléculaire des animaux
Médecine régénérative
Publications
View all-
article Akbari-Taemeh M, Péron AK, Lescot T, Seniwal B, Landreville S, Beaulieu L, Fortin MA
High-performance dosimetric gel for low-dose-rate 3D-printed brachytherapy devices
Phys Med Biol 2026.
-
article Flores-González RE, Goncalves C, Wirasinghe N, Gaudreault V, Noda Ferro JM, Coutant K, Mitchell A, Papadopoulos T, Cho YY, Guettler E, González-Moreno DR, Preston S, Cai F, Gagnon N, Jean S, Landreville S, Miller WH, Del Rincón SV
RAB1A is a novel vulnerability in uveal melanoma revealed by dual inhibition of MNK1/2 and mTOR
Cell Death Differ 2026.
-
article Karami S, Charpentier P, Landreville S, Proulx S
Pigment epithelium-derived factor and osteopontin protect human retinal pigment epithelial cells from oxidative stress in 2D and 3D models
Free Radic Biol Med 247 2026.
Projects
- IDENTIFICATION DE VULNERABILITES EXPLOITABLES DANS LE MELANOME UVEAL, from 2024-02-01 to 2027-02-01
- CORRECTION PAR PRIME EDITING DE MUTATIONS RESPONSABLES DE MALADIES HEREDITAIRES DE L'OEIL, from 2024-03-01 to 2027-03-31
- Analyse du potentiel thérapeutique des N-phénylureido-benzénesulfonates dans le mélanome oculaire, from 2025-02-26 to 2026-12-31
- NSERC CREATE in nanoparticles characterization: Innovation in Cascade Assays and Reaction to biological Environments for future nano medicines (ICARE-Nanomed), from 2026-04-01 to 2032-03-31
- Analyse du potentiel thérapeutique d'un anti-MYC dans le mélanome oculaire, from 2025-10-01 to 2026-09-30
- Roles of melanocytes in choroid homeostasis, from 2026-04-01 to 2031-03-31
- Identification de vulnérabilités exploitables dans le mélanome uvéal métastatique, from 2023-05-01 to 2025-04-30
- Creating a biomimetic 3D engineered model of the liver metastatic niche, from 2024-03-31 to 2026-03-30